References
- Geria M. Understanding the anti-aging power of peptides. Happi 2011;126:46–47
- Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci 2009;31:327–345
- Ruiz MA, Clares B, Morales ME, et al. Preparation and stability of cosmetic formulations with an anti-aging peptide. J Cosmet Sci 2007;58:157–171
- Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci 2002;24:303–310
- Gutierrez LM, Canaves JM, Ferrer-Montiel AV, et al. A peptide that mimics the carboxy-terminal domain of SNAP-25 blocks Ca+-dependent exocytosis in chromaffin cells. FEBS Lett 1995;372:39–43
- Gutierrez LM, Viniegra S, Rueda J, et al. A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. J Biol Chem 1997;272:2634–2639
- Blanes-Mira C, Merino JM, Valera E, et al. Small peptides patterned after the N-terminus domain of SNAP25 inhibit SNARE complex assembly and regulated exocytosis. J Neurochem 2004;88:124–135
- Benedetto AV. The cosmetic use of botulinum neurotoxin type A. Int J Dermatol 1999;38:641–655
- Foran PG, Mohammed N, Lisk GO, et al. Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A: basis for the distinct durations of inhibition of exocytosis in central neurons. J Biol Chem 2003;278:1363–1371
- Benson HAE, Namjoshi S. Proteins and peptides: strategies for delivery to and across the skin. J Pharm Sci 2008;97:3591–3610
- Linter K, Peschard O. Biologically active peptides: from laboratory bench curiosity to functional skin care product. J Cosmet Sci 2000;22:207–218
- Zhou W, Wang PW, Krynitsky AJ, Rader JI. Rapid and simultaneous determination of hexapeptides (Ac-EEMQRR-amide and H2N-EEMQRR-amide) in anti-wrinkle cosmetics by hydrophilic interaction liquid chromatography–solid phase extraction preparation and hydrophilic interaction liquid chromatography with tandem mass spectrometry. J Chromatogr 2011;1218:7956–7963
- Zhou W, Wang PW, Ogunsola OA, Kraeling MEK. Rapid determination of hexapeptides by hydrophilic interaction LC–MS/MS for in vitro skin penetration studies. Bioanalysis 2013;5:1353–1362
- Ogiso T, Iwaki M, Tanino T, et al. In vitro skin penetration and degradation of peptides and their analysis using a kinetic model. Biol Pharm Bull 2000;23:1346–1351
- Kraeling MEK, Bronaugh RL. In vitro percutaneous absorption of alpha hydroxy acids in human skin. J Soc Cosmet Chem 1997;48:187–197
- Collier SW, Sheikh M, Sakr A, et al. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. Toxicol Appl Pharmacol 1989;99:522–533
- Bronaugh RL, Kraeling MEK, Yourick JJ. Determination of percutaneous absorption by in vitro techniques. In: Bronaugh RL, Maibach HI, eds. Percutaneous absorption, 4th ed. New York: Marcel Dekker; 2005:265–269
- Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies VI: preparation of the barrier layer. J Pharm Sci 1986;75:487–491
- Bronaugh RL, Stewart RF, Simon M. Methods for in vitro percutaneous absorption studies VII: use of excised human skin. J Pharm Sci 1986;75:1094–1097
- Lungu C, Considine E, Zahir S, et al. Pilot study of topical acetyl hexapeptide-8 in the treatment for blepharospasm in patients receiving botulinum toxin therapy. Eur J Neurol 2013;20:515–518
- Bronaugh RL, Kraeling MEK, Yourick JJ. Skin metabolism during in vitro percutaneous absorption. In: Bronaugh RL, Maibach HI, eds. Percutaneous absorption. 4th ed. New York: Marcel Dekker; 2005:45–49
- Hood HL, Kraeling MEK, Robl MG, Bronaugh RL. Alpha hydroxy acids: in vitro absorption into viable skin and in vivo effects on the skin barrier of hairless guinea pigs. Food Chem Toxicol 1999;37:1105–1111